DOCSLIB.ORG

Curriculum Vitae JANET KAZUKO YAMAMOTO, Ph.D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Curriculum Vitae JANET KAZUKO YAMAMOTO, Ph.D. PRESENT POSITION: RESIDENCE: Professor 4309 SW 77th Street Department of Infectious Diseases & Pathology (ID&P) Gainesville, Florida 32608 College of Veterinary Medicine Phone: (352) 371-9219 University of Florida, PO Box 110880 Fax: (352) 337-0444 Gainesville, FL 32611-0880 Phone: (352) 294-4145 Fax: (352) 392-7128 E-mail: [email protected] EMPLOYMENT HISTORY: 1979-1981 James W. McLaughlin Predoctoral Fellow in Infection and Immunity, Department of Microbiology, The University of Texas Medical Branch, Galveston, (Supervisor, Dr. Howard M. Johnson). Characterized the xenogeneic responses observed during the interaction of human peripheral blood lymphocytes and mouse spleen cells. Identified human natural killer cell activity towards mouse immunocytes, nonspecific soluble helper activity of human T cells towards mouse antibody response, and suppressor cell activity of mitogen and alloantigen-stimulated human T cells towards mouse antibody response. 1981-1982 NIH PHS Postdoctoral Fellow in the laboratory of Drs. Richard W. Dutton and Susan L. Swain, Department of Biology, University of California, San Diego. Evaluated the role of lymphokines (interleukin-2 and interferon-γ) in the developing primary and secondary antibody responses in mice. 1982-1983 Research Associate Scientist in the laboratory of Drs. Robert A. Good and N.K. Day, Oklahoma Medical Research Foundation, Oklahoma City. Analyzed the immunological status of feline leukemia virus (FeLV)-positive cats that were undergoing ex vivo immunoabsorption therapy with protein A column. 1983-1985 Postgraduate Researcher IV in the Department of Medicine, School of Veterinary Medicine, University of California, Davis. Produced and purified feline interferons (α, ß, and γ) and characterized their effect against FeLV. Received New Investigator Research Award (1984-1987) from NCI, NIH to conduct research on the role of lymphokines in FeLV-induced immunosuppression and leukemia. Recruited concurrently in the fall of 1984 by Dr. Murray B. Gardner to establish the UCD AIDS Laboratory and to supervise the large-scale production and purification of HIV isolates for the Department of Pathology, School of Medicine, UCD. 1985 -1991 Assistant Research Immunologist I, II, III, IV, in the Department of Medicine, School of Veterinary Medicine, University of California, Davis. Served as a member of Center Janet K. Yamamoto for AIDS Research (CFAR) at UCD and directed a research program on characterization of FIV immunopathogenesis, development of effective FIV vaccines, and identifying innovative immunotherapeutic approaches against animal and human AIDS. 1991-1993 Adjunct Associate Professor I (starting July 1, 1992) / Associate Research Immunologist I (1991 to June 30, 1992) in the Department of Medicine, School of Veterinary Medicine, University of California, Davis. Served as a member of CFAR at UCD and directed a research program identifying immune mechanism(s) of FIV vaccine protection and determining the immunopathological effects of B-cell hyperactivities in FIV infected cats. 1993-present. Associate Professor (tenured 1997) / Professor (promoted 2001) in the Department of Infectious Diseases & Pathology*, College of Veterinary Medicine, University of Florida, Gainesville, Florida. Responsible for teaching and coordinating veterinary immunology course (1993-2005); research director of the FIV vaccine and immunotherapy program; founder and executive member of Comparative Clinical Immunology Program. Affiliate faculty of Microbiology and Cell Sciences, Institute of Food and Agricultural Sciences (IFAS), University of Florida (1993-pres.). * Please note that the Department of Infectious Diseases & Pathology was initially called the Department of Pathobiology upon fusion of two College of Veterinary Medicine (CVM) departments, the Department of Comparative & Experimental Pathology and the Department of Infectious Diseases, and to its current name in December of 2005. EDUCATION: 1976 B.A. in Biological Sciences, University of California, Davis, California. 1981 Ph.D. in Microbiology (Immunology major, Virology minor), The University of Texas Medical Branch, Galveston, Texas. MEMBERSHIP IN SCIENTIFIC ORGANIZATIONS: American Association of Immunologists American Society for Microbiology American Association for the Advancement of Science New York Academy of Sciences International AIDS Society Clinical Immunology Society 2 Janet K. Yamamoto HONORS: 1979-1981 James W. McLaughlin Predoctoral Fellow in Infection and Immunity. 1984-1987 New Investigator Research Award, NCI, NIH. 1988 Rhone Merieux Workshop on Animal AIDS Models (Invited Speaker), Lyon, France. 1988 World Health Organization Conference on Animal Models of AIDS (Invited Speaker), Geneva, Switzerland. 1991 International Feline Immunology and Immunodeficiency Workshop (Invited Speaker), Glasgow, UK. 1992 Septieme Colloque Des Cent Gardes on Retroviruses of Human AIDS and Related Animal Diseases (Invited Speaker), Pasteur Institute, Marnes-la-Coquette, France. 1993 Annual Meeting by NIH, NCI, Laboratory of Tumor Cell Biology (Invited Speaker). 1995 XVIII Symposium of the International Association for Comparative Research on Leukemia and Related Diseases in Kyoto, Japan (Invited Speaker). 1996 Pfizer Animal Health Award for Research Excellence at the University of Florida, College of Veterinary Medicine (cited in JAVMA, 209:710). 1997 Plenary lecturer for Vaccine Section, 2nd Intl. Feline Immunol. Workshop, Davis, CA. 2002 The University of Florida Research Foundation Professors Award. 2002 Honorary Member of Upsilon Chapter of The Society of Phi Zeta (Honor Society of Veterinary Medicine). 2002 America’s Registry of Outstanding Professionals. 2003 Who’s Who in Veterinary Medicine Higher Education. 2003 Who’s Who in Science and Engineering. 2005 Pfizer Animal Health Award for Research Excellence at the University of Florida, College of Veterinary Medicine (received this award twice). 2006 Who’s Who in America. 2007 Faculty Achievement Recognition at the University of Florida. 2014 National Academy of Inventors (NIA) Fellow. 2015 Congressional Record – Extension of Remarks on 02/20/2015 on 2014 NAI 2015 Florida Inventors Hall of Fame. PROFESSIONAL ACCOMPLISHMENTS: BSL-3 Laboratories • Assisted in establishing the first UCD AIDS BSL-3 laboratory in 1984 as a joint venture for the Schools of Medicine and Veterinary Medicine; in charge of large-scale production of three HIV-1 strains for development of immunodiagnostics. This laboratory eventually became UCD AIDS Diagnostic Laboratory in 1986 which served as a major HIV-1 BSL-3 facility for the Center for AIDS Research (CFAR) grant awarded to UCD. • Served as the member of the NIH-funded CFAR at UCD (1985-1993) and pursued independent research program in retrovirology and immunology in the second AIDS BSL-3 laboratory. 3 Janet K. Yamamoto • Established and successfully operated numerous BSL-2+ and BSL-3 laboratories. Served as a consultant to the development of the second FDA-approved HIV immunoblot by Bio-Rad Laboratories in 1988. Directed and managed collaborative research projects on evaluating relative efficacies of therapeutic drugs and vaccine approaches against a number of feline and human viral infections. The work on HIV included evaluating in vitro drug efficacy and toxicity. Discoveries and Developments • Co-discovered, characterized, and co-patented the feline interferon-/ (U.S. Patent No. 4,861,720) (1986). Performed phase-I trials as a joint venture with a Japanese firm under UCD contract (1988-1990). Released feline interferon license to a Japanese biochemical corporation for therapeutic use in viral diseases of cats and dogs. Currently receiving royalty income. • Co-discovered, characterized, and co-patented the FIV (U.S. Patent Nos. 5,037,753; 5,118,602) (1986-1987). This virus which closely mimics human immunodeficiency virus (HIV) is useful in studying the pathogenesis of lentiviruses, in testing combinations of antiviral and immunomodulating drugs, and in evaluating vaccine approaches for AIDS. Developed, characterized, and patented IL-2-independent FIV producer cell lines to be used for developing FIV vaccine and diagnostics (U.S. Patent Application No. 5,275,813; 5,275,813; 5,510,106) (1990). • Developed, characterized, and patented multi-subtype FIV vaccines (U.S. Patent No. 6,447,993B1; European PCT: Patent No. 728750) (1993-2001) at the University of Florida. Our dual-subtype FIV vaccine, released by Fort Dodge Animal Health in 2002, is the first commercial AIDS lentivirus vaccine. Developed and patented feline IL-2-independent cell lines useful for large-scale FIV production (U.S. Patent No. 5,846,825) (1994-1997). Currently receiving royalty and licensing income for both FIV diagnostics and vaccines. Donated a portion of FIV vaccine income to develop the College of Veterinary Medicine’s Comparative Clinical Immunology Program which had a faculty membership of 17 (14 tenured) in 2000. In collaboration with Dr. Ben Dunn of College of Medicine, University of Florida in 1997-2001 on the development and use of FIV/HIV-1 protease inhibitors leading to joint patent application (US Patent US6,875,773B1). • Discovered, characterized, and patented evolutionarily conserved T-cell epitopes on FIV and HIV-1 p24 and reverse transcriptase as immunogen for HIV-1 vaccine for humans and second generation FIV vaccine for cats (Provisional Application No. 61/681,014; No. 61/684,592; 61/841,122). Experience as Instructor, Reviewer,
Recommended publications
  • 2008-2009Program Highlights

    2008-2009Program Highlights

    AIDS FOUNDATION OF CHICAGO 2008-2009 PROGRAM HIGHLIGHTS The AIDS FOUNDATION OF CHICAGO is a force for change. We pursue a broad range of activities to end new infections, improve the lives of people with HIV, and strengthen government and community responses to the epidemic. Founded in 1985 by community activists and physicians, we fortify local, national, and international HIV-related activities. We specialize in efforts to: • Advocate with and for people affected by HIV/AIDS. • Fund and coordinate prevention, care, and advocacy projects. • Cultivate the capacity and expertise of individuals and organizations dedicated to ending HIV/AIDS. Together with our individual, government, and community partners, we reach tens of thousands of people in need each year and make our collective efforts better and stronger. We are a source of hope—a force for change. The AIDS Foundation of Chicago dedicates this report to the tens of thousands of Illinoisans affected by HIV/AIDS and the many dedicated volunteers and professionals who, through their daily activities, champion compassion and action in the wake of the HIV/AIDS crisis. A Force for Change Table of Contents: A message from the President/CEO, Board Chair and SPC Chair 7 Leadership and advocacy 8 Prevention and care 10 Preparing for the future 12 AFC 2.0: Our online presence 14 Special events 16 Financial summary 18 Corporate and Foundation Supporters 19 The Year Ahead 20 2009 Calendar of Events 21 Individual Donors 22 Board of Directors and Staff 27 Service Providers Council Executive Committee & Junior Board 28 AFC’s Service Providers Council 29 Thank You 30 A Look Back 31 Message from President/CEO, Board Chair, and SPC Chair Dear Friends: For nearly 25 years, the AIDS Foundation of Chicago (AFC) has been a source of hope and a force for change, working with key partners to reduce HIV transmission and improve the lives of people with and at risk for HIV through advocacy, funding, and collaboration.
  • California Asian American Artists Biographical Survey Records

    California Asian American Artists Biographical Survey Records

    http://oac.cdlib.org/findaid/ark:/13030/kt4d5nf319 Online items available Guide to the California Asian American Artists Biographical Survey Records Stanford University. Libraries.Department of Special Collections and University Archives Stanford, California October 2010 Copyright © 2015 The Board of Trustees of the Leland Stanford Junior University. All rights reserved. Note This encoded finding aid is compliant with Stanford EAD Best Practice Guidelines, Version 1.0. Guide to the California Asian SC0929 1 American Artists Biographical Survey Records Overview Call Number: SC0929 Creator: Stanford University Title: California Asian American artists biographical survey records Dates: circa 1850-2007 Physical Description: 25 Linear feet Summary: The collection contains biographical files on more than 1000 artists active in California between 1850 and 1965, biographical files for 91 artists not active in California, and reference files. Biographical files contain exhibition records, catalogs, press coverage, and examples of art work (in the form of slides or photographs); in some cases there is also correspondence and/or interviews. Some materials may be photocopies. The reference files contain similar materials but are arranged by subject. Because of date range of the project and the nature of immigration before the 1970s, artists of Chinese and Japanese ancestry predominate in these files. Language(s): The materials are in English. Repository: Department of Special Collections and University Archives Green Library 557 Escondido Mall Stanford, CA 94305-6064 Email: [email protected] Phone: (650) 725-1022 URL: http://library.stanford.edu/spc Information about Access This collection is open for research. Ownership & Copyright All requests to reproduce, publish, quote from, or otherwise use collection materials must be submitted in writing to the Head of Special Collections and University Archives, Stanford University Libraries, Stanford, California 94304-6064.
  • Message from the Dean

    Message from the Dean

    Developing the Next Generation of Healthcare Leaders ANNUAL REPORT 2009-10 Message from the Dean Solid Foundation Prepares Strong Future As I look back on our accomplishments during the 2009-2010 academic year, I am reminded of one of our greatest accomplishments to date – the Groundbreaking Ceremony for John and Editha Kapoor Hall. This event represents the beginning of our future as well as the focus of all we currently strive to achieve and enhance. Kapoor Hall will allow us to attain our curricular objectives, advance our research, expand collegial interactions and assist all members of the school in reaching their goals. The September 2009 Groundbreaking Ceremony laid the foundation for our occupancy of the building in the Summer of 2012. Our PharmD students were very active in pharmacy and healthcare policy objectives. Legislatively, SPAWNY organized a very successful Pharmacy Legislative Advocacy Day where local legislators visited the school and spoke with students about state health care policy and budget. APhA-ASP tackled legislative issues with the creation of a video showing how pharmacy impacts heath care reform at the local and regional levels. This was submitted to APhA as well as state and federal congressional offices. Nationally, the UB Team again took top honors with fourth place recognition at the AACP’s Pruitt-Schutte Business Plan Competition. On campus, our students represented the school well by their invited participation at the UB Celebration of Academic Excellence where PharmD and pharmaceutical sciences students showcased their research work via poster presentations. The continued high caliber work of our faculty continues to be recognized.
  • Register of Medical Institutions Issuing COVID-19 Testing

    Register of Medical Institutions Issuing COVID-19 Testing

    Register of Medical Institutions Issuing COVID-19 Testing Certificates as of September 20th, 2021 【About Antigen test kit (qualitative antigen test)】 ・In Japan, PCR Test including LAMP Method and Quantitative Antigen Test are permitted for asymptomatic patient as appropriate test method, but Antigen test kit (qualitative antigen test) are not permitted. ・At the request of the destination, Antigen test kit (qualitative antigen test) is used for asymptomatic patient, and if the test result is positive, PCR Test or other appropriate test method may be performed based on doctor's judgement. ※Permitted test method in Japan are highlighted in light blue at the table below. ※Reference: Guidelines for COVID-19 Pathogen Test Basic Information of Medical Institution Inspection Information Contact Address Testing Methods for Issuing a Certificate Information TeCOT PCR Testing PCR Testing Antigen Testing Antigen Testing No Reservation LAMP Method Other Methods Real-Time Method Non-Real-Time Method Simple Kit Quantitative Availability Medical Institution Name Phone Prefecture Municipality Street Address Nasopharynx Saliva Nasopharynx Saliva Nasopharynx Saliva Nasopharynx Saliva Nasopharynx Saliva Nasopharynx Saliva Number Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Min. Req. Availability Availability Availability Availability Availability Availability Availability Availability Availability Availability Availability Availability Time Time Time Time Time Time Time Time Time Time Time Time
  • The White Ravens 2020

    The White Ravens 2020

    2020 | The White Ravens The White Ravens White | he Rav T en A Selection of International Children‘s and Youth Literature s l 2 0 2020 2 0 I n t e r n a t io na le k J the ugendbiblio Emma AdBåge Stiftung Internationale Jugendbibliothek · Schloss Blutenburg · München · www.ijb.de Internationale Jugendbibliothek 2020 | The White Ravens A Selection of International Children‘s and Youth Literature Stiftung Internationale Jugendbibliothek IMPRESSUM The White Ravens 2020 This publication is available as PDF at: A Selection of International Children‘s and Youth Literature bit.ly/WhiteRavens2020 The White Ravens Database: Copyright © 2020 by Stiftung Internationale Jugendbibliothek whiteravens.ijb.de/list Editor: Dr. Christiane Raabe Editorial work: Jochen Weber Stiftung Internationale Jugendbibliothek Translation: Dr. Frances Bottenberg, Claudia Söffner Schloss Blutenburg Copy editing: Dr. Nikola von Merveldt Seldweg 15 81247 Munich, Germany Tel.: +49 89 8912110 Selection and texts: E-mail: [email protected] Theodora Arampatzi [TA]: Greek | Prof. Dr. Young Eun Chang www.ijb.de [YC], Prof. Dr. Moonsun Choi [MC] and Prof. Dr. Sojin Park [SP]: Korean | Toin Duijx [TD]: Dutch, Frisian | Prof. Dr. Fang Weiping ISSN 1818-6319 [FW] and Dr. Zhao Xia [ZX]: Chinese | Dr. Ines Galling [IG]: Danish, Finnish, German, Icelandic, Norwegian, Swedish | The Stiftung Internationale Jugendbibliothek (International Youth Library Dr. Azad Hamoto [AH]: Arabic | Dr. Leila (Roya) Maktabi Fard Foundation) is institutionally funded by: German Federal Ministry of Family [RM]: Persian (Farsi) | Reina Nakano [RN]: Japanese | Affairs, Senior Citizens, Women and Youth; Bavarian State Ministry for Science and the Arts; City of Munich. Lucia Obi [LO]: Chinese, Filipino, Myanmar | Claudia Söffner [CS], with the support of Betsy Bird, Michelle Bourgeois [MB], Valerie Coghlan, Áine Ní Ghlinn, Dr.
  • Friends of Aids Research Alliance Stay Busy This Fall

    Friends of Aids Research Alliance Stay Busy This Fall

    WINTER 2007 | VOLUME 17, No. 2 AIDS RESEARCH SEARCHLIGHT ALLIANCE A NATIONAL LEADER IN FAST-TRACK AIDS RESEARCH In This Issue– 2 Message from the CEO 3 News and Views 5 HIV Viral Reservoirs: Barriers to a Cure 10 Viral Eradication: A Continuing Debate 12 Measuring The HIV Reservoir 14 Current Research and Clinical Trials at ARA 16 Can Animals Help? 17 Interview with Robert Siliciano, M.D., Ph.D. 18 Health Literacy: A Tool for People Living With HIV/AIDS 20 AIDS Research Alliance Welcomes New Members to the Board of Directors 21 Friends of AIDS Research Alliance Busy This Fall 25 An Evening with Nobel Laureate David Baltimore, M.D.M.D. 27 Combined Federal Campaign (CFC) THE CHALLENGE OF EMPTYINGEMPTYING THE HIV RESERVOIRRESERVOIR MESSAGE FROM THE CEO SEARCHLIGHT HIV VACCINE RESEARCH: A RISKY BUSINESS NEWS FROM AIDS RESEARCH ALLIANCE A NATIONAL LEADER IN FAST-TRACK AIDS RESEARCH AIDS RESEARCH ALLIANCE was one of the clinical sites for the Merck vaccine study that recently was halted by the Data Safety Monitoring Board (DSMB). In VISION collaboration with the National Institute of Allergy and Infectious Diseases AIDS Research Alliance (ARA) envisions a future in which HIV and (NIAID) and the HIV Vaccine Trials Network (HVTN), Merck conducted a its effects on health are eliminated, and new infections are prevented. MISSION STATEMENT phase IIb study of an aden- ovirus (common cold) based AIDS Research Alliance exists to develop a cure for HIV/AIDS, medical modalities to prevent new infections and better treatments vaccine designed to stimulate for those living with HIV.
  • Best Amenity Cup Kurume International Women's Tennis 2005 ITF Women's Circuit SINGLES MAIN DRAW Week of City, Country Prize Money US$ Tourn

    Best Amenity Cup Kurume International Women's Tennis 2005 ITF Women's Circuit SINGLES MAIN DRAW Week of City, Country Prize Money US$ Tourn

    Best Amenity Cup Kurume International Women's Tennis 2005 ITF Women's Circuit SINGLES MAIN DRAW Week of City, Country Prize Money US$ Tourn. ID ITF Referee 2005/7/18 Kurume, Japan 25000 W25 Kurume Elda Matsuno St. Rank Seed Family Name First name Nationality 2nd Round Quarterfinals Semifinals Final 1 WC 241 1 HSIEH Su-Wei TPE Umpire as HSIEH 2 Q 920 30 FUJISHIRO Haruka JPN 63 62 Umpire as HSIEH 3 Q 886 28 HISAMI Kanae JPN 46 62 62 Umpire bs SEMA 4 Q 946 29 SEMA Erika JPN 61 60 Umpire as HSIEH 5 DA 590 15 TANAKA Mari JPN 36 62 63 Umpire a TANAKA 6 Q 1003 27 BAE Hae-Youm KOR 76(8) 61 UmpireBS HAMAMURA 7 Q 714 24 MIZUNO Eriko JPN 36 76(6) 63 UmpireBS HAMAMURA 8 DA 355 6 HAMAMURA Natsumi JPN 46 63 62 UmpireAS HSIEH 9 DA 333 4 LEE Ye-Ra KOR 62 62 Umpire as LEE 10 WC 1318 23 FUJII Hitomi JPN 63 61 Umpire as LEE 11 WC 1148 21 ONISHI Kaori JPN 60 60 Umpire A ONISHI 12 DA 453 9 VITAYAVIROJ Thassha THA 63 57 61 Umpire bs MORITA 13 DA 514 13 TEZUKA Remi JPN 63 64 Umpire A TEZUKA 14 DA 506 12 ARAI Maki JPN 64 36 61 Umpire bs MORITA 15 Q 978 25 AIKO Kasumi JPN 75 61 Umpire bs MORITA 16 DA 399 7 MORITA Ayumi JPN 61 61 Winner: asHSIEH 17 DA 351 5 YONEMURA Tomoko JPN as 62 63 UmpireAS YONEMURA, T 18 DA 593 16 YABE Yukiko JPN 61 62 Umpire b TAKAO 19 DA 519 14 TAKAGISHI Tomoyo JPN 36 62 63 Umpire B TAKAO 20 DA 486 11 TAKAO Erika JPN 46 62 63 Umpire a TAKAO 21 DA 632 18 KATSUMI Shizu JPN 16 62 64 Umpire b CHANG 22 DA 456 10 CHANG Kyung-Mi KOR 62 60 Umpire bs TAKASE 23 WC 1303 22 SHIMIZU Sakiko JPN 60 63 UmpireBS TAKASE 24 DA 277 3 TAKASE Ayami JPN 60 63 Umpire a TAKAO 25 DA 404 8 YONEMURA Akiko JPN 16 64 62 UmpireAS YONEMURA, A 26 Q 1000 31 MIYAZAKI Yumi JPN 63 64 Umpire b MAEKAWA 27 DA 609 17 MAEKAWA Ayaka JPN 63 62 Umpire A MAEKAWA 28 DA 710 20 KIM Hye-Mi KOR 63 10 RET.

  • NTT Technical Review, Apr. 2015, Vol. 13, No. 4

    NTT Technical Review April 2015 Vol. 13 No. 4 Feature Articles: Keynote Speeches at NTT R&D Forum 2015 Hiroo Unoura, Representative Director and President, Chief Executive Officer, NTT Value Creation by Collaboration Hiromichi Shinohara, Representative Director and Senior Executive Vice President, Chief Technology Officer and Senior Vice President of Research and Development Planning, NTT Co-Innovation Leading to the Future Feature Articles: Media System Technology for Creating an Appealing User Experience Creating an Appealing User Experience by Applying Media System Technology Media Processing Technology for Achieving Hospitality while on the Go Media Processing Technology for Achieving Hospitality in Information Search Media Processing Technology for Business Task Support Audio-visual Technology for Enhancing Sense of Presence in Watching Sports Events Global Standardization Activities R!SE Initiative Activities of the United Nations Practical Field Information about Telecommunication Technologies Inspection Method for Near-ground Corrosion in Steel Poles for More Efficient Facility Management External Awards/Papers Published in Technical Journals and Conference Proceedings External Awards/Papers Published in Technical Journals and Conference Proceedings Feature Articles: Keynote Speeches at NTT R&D Forum 2015 Value Creation by Collaboration Hiroo Unoura Representative Director and President, Chief Executive Officer, NTT Overview This article introduces NTT Group initiatives towards 2020 centered on global cloud business and network services. The content of this article is based on the keynote lecture presented by NTT Representative Director, President and Chief Executive Officer Hiroo Unoura at NTT R&D Forum 2015 held February 19–20, 2015. Keywords: cloud, collaboration, cybersecurity 1. 30 years since NTT privatization equates to more than one broadband-capable handset per capita in Japan.
  • New Publications 2018

    New Publications 2018

    NEW PUBLICATIONS 2018 FUKUINKAN SHOTEN PUBLISHERS From“LITTLE CHICK” Illustrations ⓒ Akiko Hayashi 2013 PICTURE BOOKS hardcover LITTLE CHICK WHICH FLOWER DO YOU LIKE BEST? A JUMPING BEETLE by Kiyoshi Soya by Mariko Ishige by Junko Masuda illustrated by Akiko Hayashi illustrated by Katsuji Wakisaka Wearing a solid dark shiny coat of armor with a Little Chick is set out for a walk…but at this Big and brilliant red flower, sleek and slender huge horn, the appearance of beetles seem quite hour? It is going to be dark shortly. Soon the air white flower, lovely little yellow flowers.... Each peculiar to us and take our breath away. This becomes thick. He pulls a fallen leaf over himself spread is bright with vividly colored flowers jumping beetle is no exception. The humorous and falls asleep. Before dawn, he feels so warm illustrated by K. Wakisaka. So explore this look of it seems even wonderful when it hops on and comfortable only to notice that Mommy “flower garden” with bouncing rhythm of the one foot, then takes a big step and finally jumps Hen has come to find him! Delicate hues in the text by M. Ishige. No need to choose just one up into the air! drawings suggest Little Chick’s sentiment favorite flower; all the wonderful flowers are 10 months and up / 21×20cm / 20 pages / ¥800.- enhancing the whole story. yours to enjoy! ISBN 978-4-8340-8329-3 10 months and up / 21×20cm / 20 pages / ¥800.- 10 months and up / 21×20cm / 20 pages / ¥800.- ISBN 978-4-8340-8314-9 ISBN 978-4-8340-8322-4 DROOLY BABY LET’S TAKE A BATH WITH GOOD MORNING STARSHINE by Sachi Kokaze QUACK-QUACK by Kyong-Mi Park illustrated by Kenji Oikawa by Kaori Katsuya illustrated by Morikazu Kumagai Babies’ laughter is drooly laughter.
  • The 67Th Annual Meeting of the International Society Of

    The 67Th Annual Meeting of the International Society Of

    Program of the 67th Annual Meeting of the International Society of Electrochemistry i The 67th Annual Meeting of the International Society of Electrochemistry Electrochemistry: from Sense to Sustainability 21-26 August, 2016 The Hague, The Netherlands CONTENTS LIST Organizing Committee ..................................................................................................................v Symposium Organizers ..........................................................................................................vi-vii Tutorial Lectures ....................................................................................................................... viii Plenary Lectures ...........................................................................................................................ix Prize Winners .......................................................................................................................... x-xii ISE Society Meetings ................................................................................................................ xiii Poster Sessions ........................................................................................................................... xii General Information ........................................................................................... inside front cover Registration Hours during the Meeting ..................................................... inside front cover On Site Registration Fees .........................................................................
  • Minocycline Treatment for HIV-Associated Cognitive Impairment Results from a Randomized Trial

    Minocycline Treatment for HIV-Associated Cognitive Impairment Results from a Randomized Trial

    Minocycline treatment for HIV-associated cognitive impairment Results from a randomized trial N. Sacktor, MD ABSTRACT S. Miyahara, PhD Objective: We conducted a study of minocycline to assess its safety, tolerability, and efficacy for L. Deng, MS the treatment of HIV-associated cognitive impairment. S. Evans, PhD Methods: HIV-1-infected individuals with progressive neurocognitive decline were enrolled in a G. Schifitto, MD double-blind, placebo-controlled study of minocycline. Participants were randomized to receive mino- B.A. Cohen, MD cycline 100 mg or matching placebo orally every 12 hours. The primary efficacy measure was change R. Paul, PhD in a neuropsychological test composite z score (NPZ-8) from baseline to week 24. Measures of safety K. Robertson, PhD included the frequency of adverse events and changes over time in laboratory tests. After 50% of B. Jarocki, BS participants completed the double-blind phase, an interim analysis of futility for the primary outcome mea- K. Scarsi, PharmD sure was performed, and our Data and Safety Monitoring Board recommended early study termination. R.W. Coombs, MD, Results: A total of 107 HIV-1-infected individuals with cognitive impairment were enrolled. The PhD minocycline group did not show improvement in the primary outcome measure (NPZ-8) (mean M.C. Zink, DVM, PhD 24-week change ϭ 0.12) compared to placebo (mean 24-week change ϭ 0.17) (95% confidence A. Nath, MD interval ϭ [Ϫ0.26, 0.39], p ϭ 0.70). There were few severe adverse events or laboratory abnor- E. Smith, MD malities in either treatment group. R.J.
  • Notice of Names of Persons Appearing to Be Owners of Abandoned Property

    Notice of Names of Persons Appearing to Be Owners of Abandoned Property

    NOTICE OF NAMES OF PERSONS APPEARING TO BE OWNERS OF ABANDONED PROPERTY Pursuant to Chapter 523A, Hawaii Revised Statutes, and based upon reports filed with the Director of Finance, State of Hawaii, the names of persons appearing to be the owners of abandoned property are listed in this notice. The term, abandoned property, refers to personal property such as: dormant savings and checking accounts, shares of stock, uncashed payroll checks, uncashed dividend checks, deposits held by utilities, insurance and medical refunds, and safe deposit box contents that, in most cases, have remained inactive for a period of at least 5 years. Abandoned property, as used in this context, has no reference to real estate. Reported owner names are separated by county: Honolulu; Kauai; Maui; Hawaii. Reported owner names appear in alphabetical order together with their last known address. A reported owner can be listed: last name, first name, middle initial or first name, middle initial, last name or by business name. Owners whose names include a suffix, such as Jr., Sr., III, should search for the suffix following their last name, first name or middle initial. Searches for names should include all possible variations. OWNERS OF PROPERTY PRESUMED ABANDONED SHOULD CONTACT THE UNCLAIMED PROPERTY PROGRAM TO CLAIM THEIR PROPERTY Information regarding claiming unclaimed property may be obtained by visiting: http://budget.hawaii.gov/finance/unclaimedproperty/owner-information/. Information concerning the description of the listed property may be obtained by calling the Unclaimed Property Program, Monday – Friday, 7:45 am - 4:30 pm, except State holidays at: (808) 586-1589. If you are calling from the islands of Kauai, Maui or Hawaii, the toll-free numbers are: Kauai 274-3141 Maui 984-2400 Hawaii 974-4000 After calling the local number, enter the extension number: 61589.